Suppr超能文献

血清Dickkopf-1作为胃肠道癌症筛查的生物标志物:一项系统评价和荟萃分析。

Serum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis.

作者信息

Liang Bin, Zhong Liansheng, He Qun, Wang Shaocheng, Pan Zhongcheng, Wang Tianjiao, Zhao Yujie

机构信息

Key Laboratory of Cell Biology, Biochip Center, Ministry of Public Health, China Medical University, Shenyang, People's Republic of China.

出版信息

Onco Targets Ther. 2015 Oct 22;8:3115-22. doi: 10.2147/OTT.S93152. eCollection 2015.

Abstract

OBJECTIVE

Despite advances in the early diagnosis of gastrointestinal (GI) cancers, these cancers are often being detected rather late in their course. Emerging published data on the accuracy of dickkopf-1 (DKK1) for diagnosing GI cancers are inconsistent. The purpose of this systematic review and meta-analysis was to evaluate the diagnostic value of DKK1 in the diagnosis of GI cancers.

METHODS

A systematic literature search of PubMed, Web of Science, Embase, Chinese National Knowledge Infrastructure, and WANFANG databases was conducted to identify the related studies published before May 1, 2015, which investigated the diagnostic value of serum DKK1 for GI cancers. The methodological quality of each study was assessed according to the Quality Assessment of Diagnostic Accuracy Studies 2 checklist. The diagnostic performance was pooled and analyzed using a bivariate model. Publication bias was evaluated with the Deeks' funnel test.

RESULTS

A total of 15 studies with 5,076 participants were finally identified for the meta-analysis. The pooled results of sensitivity (SEN), specificity (SPE), positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio for DKK1 test were 0.72 (95% confidence interval [CI]: 0.70-0.74), 0.90 (95% CI: 0.89-0.91), 7.72 (95% CI: 4.90-12.14), 0.29 (95% CI: 0.22-0.39), and 28.95 (95% CI: 16.25-51.65) for diagnosis of GI cancers, respectively. The area under the summary receiver-operating characteristic curve was 0.8901. The SEN of DKK1 in diagnosis of gastric cancer and pancreatic cancer may be higher than hepatocellular carcinoma, and the SPE in pancreatic cancer subgroup was lower than hepatocellular carcinoma and gastric cancer subgroups.

CONCLUSION

The currently available evidence suggests that serum DKK1 is a potential biomarker with high SEN and SPE for screening GI cancers. To better elucidate the usefulness of serum DKK1, further studies are needed.

摘要

目的

尽管胃肠道(GI)癌的早期诊断取得了进展,但这些癌症往往在病程晚期才被发现。关于Dickkopf-1(DKK1)诊断GI癌准确性的新发表数据并不一致。本系统评价和荟萃分析的目的是评估DKK1在GI癌诊断中的价值。

方法

对PubMed、Web of Science、Embase、中国知网和万方数据库进行系统文献检索,以识别2015年5月1日前发表的相关研究,这些研究调查了血清DKK1对GI癌的诊断价值。根据诊断准确性研究质量评估2清单评估每项研究的方法学质量。使用双变量模型汇总并分析诊断性能。用Deeks漏斗检验评估发表偏倚。

结果

最终纳入15项研究,共5076名参与者进行荟萃分析。DKK1检测的敏感性(SEN)、特异性(SPE)、阳性似然比、阴性似然比和诊断比值比的汇总结果分别为0.72(95%置信区间[CI]:0.70 - 0.74)、0.90(95% CI:0.89 - 0.91)、7.72(95% CI:4.90 - 12.14)、0.29(95% CI:0.22 - 0.39)和28.95(95% CI:16.25 - 51.65)用于诊断GI癌。汇总的受试者工作特征曲线下面积为0.8901。DKK1诊断胃癌和胰腺癌的SEN可能高于肝细胞癌,胰腺癌亚组的SPE低于肝细胞癌和胃癌亚组。

结论

现有证据表明,血清DKK1是一种具有高SEN和SPE的潜在生物标志物,可用于筛查GI癌。为了更好地阐明血清DKK1的用途,还需要进一步的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0633/4622446/deaf32448e20/ott-8-3115Fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验